ARAAX
Price
$28.21
Change
+$0.10 (+0.36%)
Updated
Jun 2 closing price
Net Assets
1.61B
HSAFX
Price
$9.70
Change
-$0.03 (-0.31%)
Updated
Jun 2 closing price
Net Assets
24.54M
Interact to see
Advertisement

ARAAX vs HSAFX

Header iconARAAX vs HSAFX Comparison
Open Charts ARAAX vs HSAFXBanner chart's image
ARAAX vs HSAFX Comparison Chart in %
View a ticker or compare two or three
VS
ARAAX vs. HSAFX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARAAX is a StrongBuy and HSAFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ARAAX has more cash in the bank: 1.61B vs. HSAFX (24.5M). HSAFX pays higher dividends than ARAAX: HSAFX (1.80) vs ARAAX (0.50). ARAAX was incepted earlier than HSAFX: ARAAX (11 years) vs HSAFX (7 years). HSAFX (2.17) is less costly to investors than ARAAX (1.40). HSAFX is a more actively managed with annual turnover of: 468.00 vs. ARAAX (172.00). HSAFX has a lower initial minimum investment than ARAAX: HSAFX (1000) vs ARAAX (2500). ARAAX annual gain was more profitable for investors over the last year : 16.70 vs. HSAFX (-0.89). ARAAX return over 5 years is better than : 14.11 vs. HSAFX (-10.33).
ARAAXHSAFXARAAX / HSAFX
Total Expense Ratio1.401.29109%
Annual Report Gross Expense Ratio1.402.1765%
Fund Existence11 years7 years-
Gain YTD12.395-1.600-775%
Front LoadN/AN/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets1.61B24.5M6,555%
Annual Yield % from dividends0.501.8028%
Returns for 1 year16.70-0.89-1,887%
Returns for 3 years35.1811.31311%
Returns for 5 years14.11-10.33-137%
Returns for 10 years57.51N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATLCP24.210.25
+1.04%
Atlanticus Holdings Corp
PRMB24.660.17
+0.69%
Primo Brands Corp.
FGNX8.16-0.32
-3.83%
FG Nexus Inc
NRIX16.36-1.03
-5.92%
Nurix Therapeutics
STTK4.87-0.78
-13.81%
Shattuck Labs